Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Head & Neck|January 21, 2025
Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell CarcinomaSeo Yoon Jang, Yun-Gyoo Lee, Sang Hoon Chun, et al.
Cancers|October 28, 2023
Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal CancerJi Eun Shin, Ho Jung An, Byoung Yong Shim, et al.
Cancer Research and Treatment|March 21, 2020
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and VomitingJin Hyoung Kang, Jung Hye Kwon, Yun-Gyoo Lee, et al.
Cancers|July 20, 2021
DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural NetworksWon Sang Shim, Kwangil Yim, Tae-Jung Kim, et al.
Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.
Journal of Gastric Cancer|May 2, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical ObservationGuk Jin Lee, Hyunho Kim, Sung Shim Cho, et al.
Cancer Research and Treatment|April 29, 2016
Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 YearsJi Hyung Hong, Kyung Sun Ha, Yun Hwa Jung, et al.
Cancer|May 29, 2023
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomasJiyun Lee, Sehhoon Park, Hyun Ae Jung, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trialDong-Wan Kim, Dae Ho Lee, Ji-Youn Han, et al.
Pageof 8